Approach to the athlete with thoracic aortic disease

Current Sports Medicine Reports

Volumn 6, Issue 2, 2007, Pages 101-107

  Saeed, Ibrahim M ^b   Braverman, Alan C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DILATATION; AORTA DISEASE; AORTA DISSECTION; ARTICLE; ATHLETE; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; EXERCISE; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE MODIFICATION; MARFAN SYNDROME; MEDICAL SPECIALIST; PHYSICAL EXAMINATION; RISK ASSESSMENT; SCREENING; THORACIC AORTA; CLINICAL PRACTICE; DISSECTING ANEURYSM; METHODOLOGY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SPORT; SPORTS MEDICINE; THORACIC AORTA ANEURYSM;

ANEURYSM, DISSECTING; AORTIC ANEURYSM, THORACIC; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; SPORTS; SPORTS MEDICINE;

EID: 34247248436     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1007/BF02941150     Document Type: Article

References (51)

1. De Paepe A, Devereux RB, Dietz HC, et al.: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996, 62:417-426.
2. Francke U, Furthmayr H: Marfan's syndrome and other disorders of fibrillin. N Engl J Med 1994, 330:1384-1385.
3. Pyeritz RE: Family history and genetic risk factors: forward to the future. JAMA 1997, 278:1284-1285.
4. Milewicz DM, Dietz HC, Miller DC: Treatment of aortic disease in patients with Marfan syndrome. Circulation 2005, 111:e150- e157. Excellent review of thoracic aortic aneurysms along with indications for surgical intervention.
5. Maron BJ, Roberts WC, McAllister HA, et al.: Sudden death in young athletes. Circulation 1980, 62:218-229.
6. Demak R: Marfan syndrome: a silent killer. Sports Illustrated 1986, 64:30-35.
7. Marsalese DL, Moodie DS, Vacante M, et al.: Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement. J Am Coll Cardiol 1989, 14:422-428; discussion 429-431.
8. Silverman DI, Burton KJ, Gray J, et al.: Life expectancy in the Marfan syndrome. Am J Cardiol 1995, 75:157-160.
9. Boyer JK, Gutierrez F, Braverman AC: Approach to the dilated aortic root. Curr Opin Cardiol 2004, 19:563-569. Well-written, concise review of aortic diseases, including the various diagnostic imaging modalities.
10. Basso C, Boschello M, Perrone C, et al.: An echocardiographic survey of primary school children for bicuspid aortic valve. Am J Cardiol 2004, 93:661-663.
11. Larson EW, Edwards WD: Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol 1984, 53:849-855.
12. Braverman AC, Guven H, Beardslee MA, et al.: The bicuspid aortic valve. Curr Probl Cardiol 2005, 30:470-522. Excellent update on the various conditions in which the bicuspid valve is seen, and its implications.
13. Braverman AC: Bicuspid aortic valve and associated aortic wall abnormalities. Curr Opin Cardiol 1996, 11:501-503.
14. Lindsay J Jr: Coarctation of the aorta, bicuspid aortic valve and abnormal ascending aortic wall. Am J Cardiol 1988, 61:182-184.
15. Oliver JM, Gallego P, Gonzalez A, et al.: Risk factors for aortic complications in adults with coarctation of the aorta. J Am Coll Cardiol 2004, 44:1641-1647.
16. Roos-Hesselink JW, Scholzel BE, Heijdra RJ, et al.: Aortic valve and aortic arch pathology after coarctation repair. Heart 2003, 89:1074-1077.
17. Ferencik M, Pape LA: Changes in size of ascending aorta and aortic valve function with time in patients with congenitally bicuspid aortic valves. Am J Cardiol 2003, 92:43-46.
18. Hahn RT, Roman MJ, Mogtader AH, Devereux RB: Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol 1992, 19:283-288.
19. Januzzi JL, Isselbacher EM, Fattori R, et al.: Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol 2004, 43:665-669.
20. Lewin MB, McBride KL, Pignatelli R, et al.: Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 2004, 114:691-696.
21. Nistri S, Sorbo MD, Marin M, et al.: Aortic root dilatation in young men with normally functioning bicuspid aortic valves. Heart 1999, 82:19-22.
22. Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J Am Coll Cardiol 1991, 17:712-716.
23. Gurvitz M, Chang RK, Drant S, Allada V: Frequency of aortic root dilation in children with a bicuspid aortic valve. Am J Cardiol 2004, 94:1337-1340.
24. de Sa M, Moshkovitz Y, Butany J, David TE: Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the Ross procedure. J Thorac Cardiovasc Surg 1999, 118:588-594.
25. Fedak PW, Verma S, David TE, et al.: Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002, 106:900-904.
26. Loeys BL, Chen J, Neptune ER, et al.: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37:275-281. Landmark article that describes this newly recognized syndrome.
27. Loeys BL, Schwarze U, Holm T, et al.: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006, 355:788-798.
28. von Kodolitsch Y, Nienaber CA, Dieckmann C, et al.: Chest radiography for the diagnosis of acute aortic syndrome. Am J Med 2004, 116:73-77.
29. Come PC, Fortuin NJ, White RI Jr, McKusick VA: Echocardiographic assessment of cardiovascular abnormalities in the Marfan syndrome. Comparison with clinical findings and with roentgenographic estimation of aortic root size. Am J Med 1983, 74:465-474.
30. Yetman AT, Bornemeier RA, McCrindle BW: Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 2003, 41:329-332.
31. Braverman AC: Exercise and the Marfan syndrome. Med Sci Sports Exerc 1998, 30:S387-395.
32. Rossi-Foulkes R, Roman MJ, Rosen SE, et al.: Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am J Cardiol 1999, 83:1364-1368.
33. Shores J, Berger KR, Murphy EA, Pyeritz RE: Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994, 330:1335-1341.
34. O'Rourke M: Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990, 15:339-347.
35. O'Rourke MF, Kelly RP, Avolio AP, Hayward C. Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load. Am J Cardiol 1989, 63:38I-44I.
36. Stefanadis C, Dernellis J, Vlachopoulos C, et al.: Aortic function in arterial hypertension determined by pressure-diameter relation: effects of diltiazem. Circulation 1997, 96:1853-1858.
37. Buckley C, Wyble CW, Borhani M, et al.: Accelerated enlargement of experimental abdominal aortic aneurysms in a mouse model of chronic cigarette smoke exposure. J Am Coll Surg 2004, 199:896-903.
38. Habashi JP, Judge DP, Holm TM, et al.: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121.
39. National Marfan Society. Atenolol vs losartan in individuals with Marfan syndrome clinical trial to begin this fall. Available at http://www.marfan.org/nmf/GetSubContentRequestHandler.do? sub_menu_item_content_id=147&menu_item_id=91#. Accessed January 23, 2007.
40. Braverman AC: Timing of aortic surgery in the Marfan syndrome. Curr Opin Cardiol 2004, 19:549-550. Editorial overview on the most recent consensus regarding when to refer patients with aortic disease to surgery.
41. Gott VL, Greene PS, Alejo DE, et al.: Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med 1999, 340:1307-1313.
42. Chiappini B, Schepens M, Tan E, et al.: Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur Heart J 2005, 26:180-186.
43. Davies RR, Goldstein LJ, Coady MA, et al.: Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002, 73:17-27; discussion 27-18.
44. de Oliveira NC, David TE, Ivanov J, et al.: Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 2003, 125:789-796.
45. Maron BJ, Mitchell JH: Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 1994, 24:848-850.
46. Buttrick PM, Scheuer J: Exercise and the heart: acute hemodynamics, conditioning, training, the athlete's heart, and sudden death. In The Heart, Arteries, and Veins. Edited by Schlant R, Alexander R, edn 8. New York: McGraw-Hill; 1997:2057-2066.
47. National Marfan Society. Marfan syndrome: physical education and activity guidelines. Available at http://www.marfan.org/nmf/ GetSubContentRequestHandler.do?sub_menu_item_content_id=43&menu_item_id=7. Accessed January 23, 2007. Very nice website reviewing exercise guidelines.
48. Elefteriades JA, Hatzaras I, Tranquilli MA, et al.: Weight lifting and rupture of silent aortic aneurysms. JAMA 2003, 290:2803.
49. Maron BJ, Ackerman MJ, Nishimura RA, et al: Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol 2005, 45:1340-1345. The latest consensus statement regarding exercise guidelines for various cardiovascular syndromes.
50. Maron BJ, Zipes DP: Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 2005, 45:1318-1321.
51. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J: Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989, 64:507-512.